B.U Technology Logo

B.U Technology

Commercializes university research via IP management, licensing, and new venture creation.

230980 | KO

Overview

Corporate Details

ISIN(s):
KR7230980005
LEI:
Country:
South Korea
Address:
부산광역시 강서구 명지국제2로28번길 34 에코팰리스 318호, 부산광역시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Boston University's Office of Technology Development (OTD) facilitates the commercialization of inventions and discoveries emerging from the university's research community. The office's primary objective is to translate groundbreaking research into market-ready applications by fostering collaborations between BU inventors and the entrepreneurial and industrial ecosystems. Key services include intellectual property management, patenting, technology licensing, and providing comprehensive support for the formation of new ventures. The OTD also connects industry partners with university researchers and offers education, tools, and mentorship to faculty, students, and alumni across sectors including life sciences, medical technology, and engineering.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-19 00:00
Legal Proceedings Report
[기재정정]회생절차개시결정
Korean 12.5 KB
2025-08-14 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.7 MB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.4 MB
2025-08-14 00:00
Audit Report / Information
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Korean 13.5 KB
2025-08-14 00:00
Regulatory News Service
기타시장안내 (투자주의 환기종목 지정사유 추가 관련 시장조치 미진행)
Korean 3.4 KB
2025-08-13 00:00
Legal Proceedings Report
[기재정정]회생절차개시결정
Korean 12.2 KB
2025-07-04 00:00
Legal Proceedings Report
기타경영사항(자율공시) (상장폐지결정 효력정지 등 가처분 신청)
Korean 6.3 KB
2025-07-04 00:00
Delisting Announcement
기타시장안내 (정리매매 보류 관련)
Korean 2.8 KB
2025-07-04 00:00
Delisting Announcement
주권매매거래정지 (투자자 보호)
Korean 4.6 KB
2025-07-03 00:00
Legal Proceedings Report
[기재정정]회생절차개시결정
Korean 11.7 KB
2025-07-03 00:00
Delisting Announcement
기타시장안내 (기업심사위원회 심의·의결 결과 안내)
Korean 2.7 KB
2025-07-03 00:00
Delisting Announcement
주권매매거래정지해제 (상장폐지에 따른 정리매매 개시)
Korean 4.4 KB
2025-06-02 00:00
Legal Proceedings Report
기타시장안내 (기업심사위원회 개최기한 연장안내)
Korean 3.7 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.4 MB
2025-05-02 00:00
Legal Proceedings Report
기타시장안내 (개선계획 이행내역서 제출에 따른 안내)
Korean 3.1 KB

Automate Your Workflow. Get a real-time feed of all B.U Technology filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for B.U Technology

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for B.U Technology via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

VALIRX PLC Logo
Advancing oncology & women's health therapeutics and offering preclinical research services.
United Kingdom
VAL
VALUE GOLF Inc. Logo
A golf services hub offering reservations, solo player bookings, e-commerce, lessons, and tours.
Japan
3931
Value HR Co., Ltd. Logo
Offers a health management platform and consulting for corporate health insurance societies in Japan.
Japan
6078
Global OTA for curated tours & experiences, focusing on travel to and from Japan.
Japan
7048
A South Korean travel company offering global tour packages, flights, hotels, and corporate travel.
South Korea
094850
Virax Biolabs Group Ltd Logo
Specializes in T-cell immunity tests and diagnostics for profiling viral disease responses.
United States of America
VRAX
VisionSys AI Inc Logo
Develops AI-powered brain-computer interfaces for the healthcare and biotech sectors.
United States of America
VSA
Vivesto Logo
Develops and licenses novel cancer therapies for humans and animals using proprietary drug delivery.
Sweden
VIVE
Vor Biopharma Inc. Logo
Clinical-stage biotech developing next-gen medicines that target the root cause of autoimmune disease.
United States of America
VOR
Voronoi, Inc. Logo
Develops selective kinase inhibitors and targeted protein degraders for precision oncology.
South Korea
310210

Talk to a Data Expert

Have a question? We'll get back to you promptly.